SUPERNUS PHARMACEUTICALS, INC. 8-K

What Happened

• Supernus Pharmaceuticals, Inc. filed a Form 8-K on February 12, 2026 announcing it expects to report its fourth-quarter 2025 business and financial results after the market close on Tuesday, February 24, 2026.
• The company will discuss those quarterly results on a conference call and webcast on February 24, 2026 at 4:30 p.m. Eastern Time. A press release issued February 12, 2026 was furnished with the filing.

Key Details

• Filing date: February 12, 2026 (Form 8-K).
• Results release date: After market close on Tuesday, February 24, 2026.
• Conference call/webcast: Tuesday, February 24, 2026 at 4:30 p.m. ET.
• Press release accompanying the 8-K was furnished as an exhibit to the filing.

Why It Matters

• This 8-K provides the schedule for Supernus’s Q4 2025 earnings disclosure and investor call—important dates for shareholders, analysts, and traders planning to review the company’s quarterly results and management commentary.
• The filing itself does not include the financial results; investors should listen to the Feb. 24 webcast or review the subsequent earnings release and Form 8-K that reports the actual figures (revenue, earnings, and business updates).